Helsinn Healthcare S.A. v. Gland Pharma Limited
consent judgment and dismissal- Docket:
- 3:22-cv-04635
- Filed:
- 2022-07-18
- Terminated:
- 2023-01-19
Helsinn sued Gland under the Hatch-Waxman Act over Gland's ANDA No. 217374 for generic fosnetupitant/palonosetron IV product, asserting ten patents including U.S. 10,828,297; the action was also cited in some sources as 2:22-cv-04635. It was resolved by consent judgment and dismissal order in January 2023, with Gland admitting technical infringement under 35 U.S.C. § 271(e)(2)(A) and enjoined from marketing the ANDA product until a redacted date; Gland's invalidity/non-infringement counterclaims were not adjudicated.